Abstract | DISEASE OVERVIEW: DIAGNOSIS: RISK STRATIFICATION: Age, hemoglobin level, platelet count, β2 microglobulin, and monoclonal IgM concentrations are characteristics that are predictive of outcomes. RISK-ADAPTED THERAPY: MANAGEMENT OF REFRACTORY DISEASE:
|
Authors | Morie A Gertz |
Journal | American journal of hematology
(Am J Hematol)
Vol. 94
Issue 2
Pg. 266-276
(02 2019)
ISSN: 1096-8652 [Electronic] United States |
PMID | 30328142
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Copyright | © 2018 Wiley Periodicals, Inc. |
Chemical References |
- Antineoplastic Agents
- Rituximab
- Bendamustine Hydrochloride
|
Topics |
- Antineoplastic Agents
(therapeutic use, toxicity)
- Bendamustine Hydrochloride
(therapeutic use)
- Humans
- Prognosis
- Risk Assessment
- Rituximab
(therapeutic use)
- Stem Cell Transplantation
- Therapeutics
(adverse effects, trends)
- Waldenstrom Macroglobulinemia
(diagnosis, therapy)
|